SciTransfer
Organization

YELLOW RESEARCH

Amsterdam SME providing training and consultancy services to Marie Curie doctoral networks across life sciences, materials, and engineering.

Innovation consultancyhealthNLSMENo active H2020 projectsThin data (2/5)
H2020 projects
4
As coordinator
0
Total EC funding
Unique partners
57
What they do

Their core work

Yellow Research is an Amsterdam-based SME that provides specialized training and consultancy services to EU-funded Marie Skłodowska-Curie doctoral training networks. Their participation as a third party across four MSCA networks spanning radically different scientific domains — from chromatin biology to solid mechanics to electrochemistry — strongly suggests they deliver transferable skills training (entrepreneurship, research methodology, science communication, or career development) rather than domain-specific research. They serve as a non-academic training partner embedded in large international PhD consortia.

Core expertise

What they specialise in

Doctoral training and transferable skillsprimary
4 projects

Third-party role in 4 MSCA-ITN networks across unrelated scientific fields indicates cross-cutting training provision

Research-to-business translationsecondary
4 projects

Consistent presence in industry-academia training networks (MSCA-ITN-ETN) suggests expertise in bridging research and commercial application

Ubiquitin biology and drug discoveryemerging
1 project

UbiCODE project (2018-2022) focused on ubiquitin-based biomarkers and drug targets, their most recent and keyword-rich engagement

Evolution & trajectory

How they've shifted over time

Early focus
Cross-domain doctoral training
Recent focus
Life sciences training networks

Yellow Research's H2020 involvement spans 2015-2022 but shows no clear thematic evolution — their projects range from chromatin dynamics and alloy coatings to structural mechanics and ubiquitin biology. This scatter across unrelated fields reinforces that their core offering is not domain expertise but rather a training or consultancy service applicable to any MSCA doctoral network. The only keyword-rich project is UbiCODE (2018-2022), which may indicate a recent deepening of engagement in life sciences and drug discovery.

Their most recent project (UbiCODE) suggests a possible tilt toward life sciences and drug discovery training, though the sample is too small to confirm a lasting shift.

Collaboration profile

How they like to work

Role: third_party_expertReach: European16 countries collaborated

Yellow Research exclusively participates as a third party — never as coordinator or even a full consortium partner. This is characteristic of organizations that provide specialized services (training, workshops, secondments) to MSCA networks without taking on major research deliverables. Despite only 4 projects, they connect to 57 partners across 16 countries, indicating they plug into large, well-established academic consortia rather than building their own.

Through just 4 MSCA training networks, Yellow Research has connected with 57 unique partners across 16 countries, reflecting the large consortium sizes typical of MSCA-ITN projects. Their network is broad but indirect — built through the consortia they join rather than through bilateral relationships.

Why partner with them

What sets them apart

Yellow Research occupies a niche as a private-sector training partner for MSCA doctoral networks. Their ability to contribute across scientifically unrelated consortia — from materials science to molecular biology — points to a portable, skills-based offering that academic groups cannot easily provide themselves. For consortium builders assembling an MSCA-ITN proposal, they represent a ready-made non-academic training component with a track record across multiple successful networks.

Notable projects

Highlights from their portfolio

  • UbiCODE
    Most keyword-rich project focused on ubiquitin-based drug targets and biomarkers — their deepest documented scientific engagement
  • Chromatin3D
    Earliest project (2015) in chromatin dynamics and disease, establishing their pattern of third-party participation in life science training networks
Cross-sector capabilities
doctoral and researcher trainingmaterials science and engineeringstructural mechanicsscience-business translation
Analysis note: Limited data: only 4 projects, all as third party with no recorded EC funding. The extreme topic diversity across projects strongly suggests a training/consultancy role rather than domain research, but without a website or detailed project descriptions, their exact service offering remains inferred. The keyword data comes almost entirely from UbiCODE; the other three projects contributed no keywords.